The present invention relates to novel, highly lipophilic silatecan intermediates and prodrugs of DB-67 and other silatecans.

 
Web www.patentalert.com

< Di-substituted pyrrolotriazine compounds

< Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use

> Androgen receptor antagonists

> Method for determining biological expression levels by linear programming
~ 00272